Research output

Research output per year 1977 2018 2020 2023

• 189 Article
• 33 Comment/debate
• 9 Review article
• 6 Letter
• 3 More
  • 2 Chapter
  • 1 Editorial

Research output per year

Research output per year

Search results

• 2023

  Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers (Nature Genetics, (2020), 52, 3, (342-352), 10.1038/s41588-019-0557-x)

  PCAWG Consortium, May 2023, In: Nature Genetics. 55, 5, p. 892 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

• Author Correction: Patterns of somatic structural variation in human cancer genomes (Nature, (2020), 578, 7793, (112-121), 10.1038/s41586-019-1913-9)

  PCAWG-Structural Variation Working Group & PCAWG Consortium, Feb 16 2023, In: Nature. 614, 7948, p. E38

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

• Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing (Nature Genetics, (2020), 52, 3, (331-341), 10.1038/s41588-019-0576-7)

  PCAWG-Structural Variation Working Group & PCAWG Consortium, Jun 2023, In: Nature Genetics. 55, 6, p. 1076 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  • Chromothripsis 100%
  • Whole Genome Sequencing 67%
  • Genome 39%
  • Neoplasms 18%

• Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes (Nature, (2020), 578, 7793, (102-111), 10.1038/s41586-020-1965-x)

  PCAWG Drivers and Functional Interpretation Working Group, PCAWG-Structural Variation Working Group & PCAWG Consortium, Feb 16 2023, In: Nature. 614, 7948, p. E40

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

• Author Correction: Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition (Nature Genetics, (2020), 52, 3, (306-319), 10.1038/s41588-019-0562-0)

  PCAWG-Structural Variation Working Group & PCAWG Consortium, Jun 2023, In: Nature Genetics. 55, 6, p. 1080 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  • Genome 100%
  • Medicine 53%
  • Neoplasms 47%
  • Baltimore 47%
  • Quebec 44%

• Author Correction: Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer (Nature Genetics, (2020), 52, 3, (294-305), 10.1038/s41588-019-0564-y)

  PCAWG-Structural Variation Working Group & PCAWG Consortium, Jun 2023, In: Nature Genetics. 55, 6, p. 1079 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  • Chromatin 100%
  • Genome 76%
  • Neoplasms 36%

• Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers (Nature Genetics, (2020), 52, 3, (342-352), 10.1038/s41588-019-0557-x)

  PCAWG Consortium, Jun 2023, In: Nature Genetics. 55, 6, p. 1078 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  • Mitochondrial Genome 100%
  • Genome 53%
  • Neoplasms 25%

• Author Correction: Butler enables rapid cloud-based analysis of thousands of human genomes (Nature Biotechnology, (2020), 38, 3, (288-292), 10.1038/s41587-019-0360-3)

  PCAWG Technical Working Group & PCAWG Consortium, Apr 2023, In: Nature biotechnology. 41, 4, p. 577 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

• Author Correction: Pan-cancer analysis of whole genomes (Nature, (2020), 578, 7793, (82-93), 10.1038/s41586-020-1969-6)

  The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium, Feb 16 2023, In: Nature. 614, 7948, p. E39

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  • Genome 100%
  • Neoplasms 47%

• Author Correction: The evolutionary history of 2,658 cancers (Nature, (2020), 578, 7793, (122-128), 10.1038/s41586-019-1907-7)

  PCAWG Evolution & Heterogeneity Working Group & PCAWG Consortium, Feb 16 2023, In: Nature. 614, 7948, p. E42

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

• Author Correction: Genomic basis for RNA alterations in cancer (Nature, (2020), 578, 7793, (129-136), 10.1038/s41586-020-1970-0)

  PCAWG Transcriptome Core Group, PCAWG Transcriptome Working Group & PCAWG Consortium, Feb 16 2023, In: Nature. 614, 7948, p. E37

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

• Author Correction: The repertoire of mutational signatures in human cancer (Nature, (2020), 578, 7793, (94-101), 10.1038/s41586-020-1943-3)

  PCAWG Mutational Signatures Working Group & PCAWG Consortium, Feb 16 2023, In: Nature. 614, 7948, p. E41

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

• Author Correction: The landscape of viral associations in human cancers (Nature Genetics, (2020), 52, 3, (320-330), 10.1038/s41588-019-0558-9)

  PCAWG Pathogens & PCAWG Consortium, Jun 2023, In: Nature Genetics. 55, 6, p. 1077 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  • Genome 100%
  • Neoplasms 47%
  • Germany 32%
  • Infections 17%

• Publisher Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers (Nature Genetics, (2020), 52, 3, (342-352), 10.1038/s41588-019-0557-x)

  PCAWG Consortium, May 2023, In: Nature Genetics. 55, 5, p. 893 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access
• 2022

  Author Correction: High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations (Nature Communications, (2020), 11, 1, (736), 10.1038/s41467-019-13885-w)

  PCAWG Transcriptome Working Group, PCAWG-Structural Variation Working Group & PCAWG Consortium, Dec 1 2022, In: Nature communications. 13, 1, 7572.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  • genome 100%
  • Gene Rearrangement 89%
  • genes 89%
  • cancer 71%
  • Communication 69%

• Author Correction: Combined burden and functional impact tests for cancer driver discovery using DriverPower (Nature Communications, (2020), 11, 1, (734), 10.1038/s41467-019-13929-1)

  PCAWG Drivers and Functional Interpretation Working Group & PCAWG Consortium, Dec 1 2022, In: Nature communications. 13, 1, 7571.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  • impact tests 100%
  • genome 79%
  • cancer 71%
  • Communication 69%
  • communication 63%

• Author Correction: A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns (Nature Communications, (2020), 11, 1, (728), 10.1038/s41467-019-13825-8)

  PCAWG Tumor Subtypes and Clinical Translation Working Group & PCAWG Consortium, Dec 2022, In: Nature communications. 13, 1, 7573.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  • Deep Learning 100%
  • genome 94%
  • passengers 93%
  • document markup languages 86%
  • mutations 84%

• Author Correction: Inferring structural variant cancer cell fraction (Nature Communications, (2020), 11, 1, (730), 10.1038/s41467-020-14351-8)

  PCAWG Evolution and Heterogeneity Working Group & PCAWG Consortium, Dec 1 2022, In: Nature communications. 13, 1, 7568.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  • genome 100%
  • cancer 71%
  • Communication 69%
  • document markup languages 68%
  • communication 63%

• Author Correction: Integrative pathway enrichment analysis of multivariate omics data (Nature Communications, (2020), 11, 1, (735), 10.1038/s41467-019-13983-9)

  PCAWG Drivers and Functional Interpretation Working Group & PCAWG Consortium, Dec 1 2022, In: Nature communications. 13, 1, 7570.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  • genome 100%
  • document markup languages 91%
  • cancer 71%
  • Communication 69%
  • communication 63%

• Author Correction: Divergent mutational processes distinguish hypoxic and normoxic tumours (Nature Communications, (2020), 11, 1, (737), 10.1038/s41467-019-14052-x)

  PCAWG Consortium, Dec 2022, In: Nature communications. 13, 1, 7569.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  • genome 100%
  • document markup languages 91%
  • tumors 73%
  • cancer 71%
  • Communication 69%

• Author Correction: Genomic footprints of activated telomere maintenance mechanisms in cancer (Nature Communications, (2020), 11, 1, (733), 10.1038/s41467-019-13824-9)

  PCAWG-Structural Variation Working Group & PCAWG Consortium, Dec 1 2022, In: Nature communications. 13, 1, 7574.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  • telomeres 100%
  • genome 76%
  • document markup languages 70%
  • footprints 66%
  • Telomere 64%

• Author Correction: Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig (Nature Communications, (2020), 11, 1, (731), 10.1038/s41467-020-14352-7)

  PCAWG Evolution and Heterogeneity Working Group & PCAWG Consortium, Dec 1 2022, In: Nature communications. 13, 1, 7567.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  • genome 100%
  • document markup languages 91%
  • mutations 89%
  • cancer 71%
  • Communication 69%

• Author Correction: Pathway and network analysis of more than 2500 whole cancer genomes (Nature Communications, (2020), 11, 1, (729), 10.1038/s41467-020-14367-0)

  PCAWG Drivers and Functional Interpretation Working Group & PCAWG Consortium, Dec 1 2022, In: Nature communications. 13, 1, 7566.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

• Phase i trial of adjuvant mature autologous dendritic cell/allogeneic tumor lysate vaccines in combination with temozolomide in newly diagnosed glioblastoma

  Parney, I. F., Anderson, S. K., Gustafson, M. P., Steinmetz, S., Peterson, T. E., Kroneman, T. N., Raghunathan, A., O'Neill, B. P., Buckner, J. C., Solseth, M. & Dietz, A. B., Jan 1 2022, In: Neuro-Oncology Advances. 4, 1, vdac089.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Temozolomide 100%
  • Cancer Vaccines 97%
  • Glioblastoma 79%
  • Dendritic Cells 72%
  • Vaccines 52%
• 2020

  A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns

  PCAWG Tumor Subtypes and Clinical Translation Working Group & PCAWG Consortium, Dec 1 2020, In: Nature communications. 11, 1, 728.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Deep Learning 100%
  • passengers 93%
  • mutations 84%
  • learning 78%
  • tumors 69%

• Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples (Nature Communications, (2020), 11, 1, (4748), 10.1038/s41467-020-18151-y)

  MC3 Working Group, PCAWG novel somatic mutation calling methods working group & PCAWG Consortium, Dec 1 2020, In: Nature communications. 11, 1, 6232.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  • genome 100%
  • Exome 92%
  • mutations 89%
  • medicine 82%
  • cancer 71%

• Combined burden and functional impact tests for cancer driver discovery using DriverPower

  PCAWG Drivers and Functional Interpretation Working Group & PCAWG Consortium, Dec 1 2020, In: Nature communications. 11, 1, 734.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • impact tests 100%
  • genome 99%
  • cancer 71%
  • Mutation 64%
  • mutations 50%

• Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing

  PCAWG-Structural Variation Working Group & PCAWG Consortium, Mar 1 2020, In: Nature Genetics. 52, 3, p. 331-341 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Comprehensive molecular characterization of mitochondrial genomes in human cancers

  PCAWG Consortium, Mar 1 2020, In: Nature Genetics. 52, 3, p. 342-352 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer

  PCAWG-Structural Variation Working Group & PCAWG Consortium, Mar 1 2020, In: Nature Genetics. 52, 3, p. 294-305 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Divergent mutational processes distinguish hypoxic and normoxic tumours

  PCAWG Consortium, Dec 1 2020, In: Nature communications. 11, 1, 737.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • hypoxia 100%
  • tumors 75%
  • Mutation 67%
  • cancer 63%
  • mutations 39%

• Final report from Intergroup NCCTG 86-72-51 (Alliance): A phase III randomized clinical trial of high-dose versus low-dose radiation for adult low-grade glioma

  Breen, W. G., Anderson, S. K., Carrero, X. W., Brown, P. D., Ballman, K. V., O'Neill, B. P., Curran, W. J., Abrams, R. A., Laack, N. N., Levitt, R., Galanis, E., Buckner, J. C. & Shaw, E. G., Jun 9 2020, In: Neuro-oncology. 22, 6, p. 830-837 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Phase III Clinical Trials 100%
  • Glioma 76%
  • Radiation 62%
  • Randomized Controlled Trials 56%
  • Progression-Free Survival 32%
  2 Scopus citations

• Genomic and phenotypic characterization of a broad panel of patient-derived xenografts reflects the diversity of glioblastoma

  Vaubel, R. A., Tian, S., Remonde, D., Schroeder, M. A., Mladek, A. C., Kitange, G. J., Caron, A., Kollmeyer, T. M., Grove, R., Peng, S., Carlson, B. L., Ma, D. J., Sarkar, G., Evers, L., Decker, P. A., Yan, H., Dhruv, H. D., Berens, M. E., Wang, Q., Marin, B. M., & 14 othersKlee, E. W., Califano, A., LaChance, D. H., Eckel-Passow, J. E., Verhaak, R. G., Sulman, E. P., Burns, T. C., Meyer, F. B., O'Neill, B. P., Tran, N. L., Giannini, C., Jenkins, R. B., Parney, I. F. & Sarkaria, J. N., Mar 1 2020, In: Clinical Cancer Research. 26, 5, p. 1094-1104 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Glioblastoma 100%
  • Heterografts 90%
  • Methylation 39%
  • RNA Sequence Analysis 32%
  • Neoplasms 28%
  16 Scopus citations

• Genomic footprints of activated telomere maintenance mechanisms in cancer

  PCAWG-Structural Variation Working Group & PCAWG Consortium, Dec 1 2020, In: Nature communications. 11, 1, 733.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • telomeres 100%
  • footprints 66%
  • Telomere 64%
  • maintenance 61%
  • tumors 56%

• High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations

  PCAWG Transcriptome Working Group, PCAWG-Structural Variation Working Group & PCAWG Consortium, Dec 1 2020, In: Nature communications. 11, 1, 736.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • RNA Sequencing 100%
  • genome 78%
  • Enhancer 71%
  • Gene Rearrangement 70%
  • genes 70%

• Inferring structural variant cancer cell fraction

  PCAWG Evolution and Heterogeneity Working Group & PCAWG Consortium, Dec 1 2020, In: Nature communications. 11, 1, 730.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • cancer 100%
  • Heterogeneity 98%
  • genome 83%
  • sequencing 58%
  • Mixture 46%

• Integrative pathway enrichment analysis of multivariate omics data

  PCAWG Drivers and Functional Interpretation Working Group & PCAWG Consortium, Dec 1 2020, In: Nature communications. 11, 1, 735.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • cancer 100%
  • genome 92%
  • Mutation 90%
  • Datasets 84%
  • genes 83%

• Outcomes of Autologous Stem Cell Transplant Consolidation in Primary Central Nervous System Lymphoma: A Mayo Clinic Experience

  Khurana, A., Micallef, I. N., LaPlant, B. R., Patrick O'Neill, B., Habermann, T. M., Ansell, S. M., Inwards, D. J., Porrata, L. F., Paludo, J., Bisneto, J. C. V. & Johnston, P. B., Dec 2020, In: Biology of Blood and Marrow Transplantation. 26, 12, p. 2217-2222 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Thiotepa 100%
  • Carmustine 80%
  • Lymphoma 57%
  • Central Nervous System 50%
  • Stem Cells 50%
  1 Scopus citations

• Pan-cancer analysis of whole genomes

  The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium, Feb 6 2020, In: Nature. 578, 7793, p. 82-93 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Genome 100%
  • Neoplasms 47%
  • Mutation 21%
  • Telomere 21%
  • Point Mutation 19%
  379 Scopus citations

• Pathway and network analysis of more than 2500 whole cancer genomes

  PCAWG Drivers and Functional Interpretation Working Group & PCAWG Consortium, Dec 1 2020, In: Nature communications. 11, 1, 729.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • network analysis 100%
  • genome 91%
  • mutations 81%
  • cancer 65%
  • Mutation 59%

• Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig

  PCAWG Evolution and Heterogeneity Working Group & PCAWG Consortium, Dec 1 2020, In: Nature communications. 11, 1, 731.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • mutations 100%
  • cancer 80%
  • Mutation 72%
  • signatures 68%
  • trajectories 67%

• Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

  MC3 Working Group, PCAWG novel somatic mutation calling methods working group & PCAWG Consortium, Dec 1 2020, In: Nature communications. 11, 1, 4748.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • genome 100%
  • Exome 92%
  • mutations 89%
  • sequencing 87%
  • cancer 71%
  3 Scopus citations

• Sex differences in oncogenic mutational processes

  PCAWG Tumour Subtypes and Clinical Translation & PCAWG Consortium, Dec 1 2020, In: Nature communications. 11, 1, 4330.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Oncogenic 100%
  • Sex Characteristics 66%
  • Mutation 60%
  • cancer 57%
  • genome 39%
  7 Scopus citations

• The landscape of viral associations in human cancers

  PCAWG Pathogens & PCAWG Consortium, Mar 1 2020, In: Nature Genetics. 52, 3, p. 320-330 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
• 2019

  Erratum: The Immune Landscape of Cancer (Immunity (2018) 48(4) (812–830.e14), (S1074761318301213), (10.1016/j.immuni.2018.03.023))

  The Cancer Genome Atlas Research Network, Aug 20 2019, In: Immunity. 51, 2, p. 411-412 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  • Immunity 100%
  • Names 77%
  • Genes 49%
  • Neoplasms 39%
  • Research Design 32%
  43 Scopus citations
• 2018

  A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers

  The Cancer Genome Atlas Research Network, Apr 9 2018, In: Cancer cell. 33, 4, p. 690-705.e9

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Atlases 100%
  • Breast Neoplasms 99%
  • Decision Trees 77%
  • Long Noncoding RNA 67%
  • Genome 63%
  168 Scopus citations

• An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics

  The Cancer Genome Atlas Research Network, Apr 5 2018, In: Cell. 173, 2, p. 400-416.e11

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Atlases 100%
  • Genome 63%
  • Survival 51%
  • Neoplasms 30%
  • Datasets 9%
  600 Scopus citations

• A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples

  The Cancer Genome Atlas Research Network, Apr 5 2018, In: Cell. 173, 2, p. 386-399.e12

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Enhancer 100%
  • Neoplasms 27%
  • Genes 14%
  • RNA-Seq 14%
  • Aneuploidy 12%
  87 Scopus citations

• A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily

  The Cancer Genome Atlas Research Network, Oct 24 2018, In: Cell Systems. 7, 4, p. 422-437.e7

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Transforming Growth Factors 100%
  • Sequence Deletion 31%
  • Neoplasms 30%
  • Genes 21%
  • Transforming Growth Factor-beta Type II Receptors 19%
  44 Scopus citations

• Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer

  The Cancer Genome Atlas Network, Apr 5 2018, In: Cell. 173, 2, p. 291-304.e6

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • MicroRNA 100%
  • Cluster Analysis 36%
  • Protein 33%
  • Neoplasms 26%
  • Aneuploidy 21%
  538 Scopus citations